Eisai announces FDA acceptance of AcipHex NDA for priority review

Download PDF Copy

Editorial Checklist

Reviewed

Nov 30 2012Eisai Inc.

Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for priority review Eisai's New Drug Application (NDA) for AcipHex® Delayed-Release Sprinkle Capsules 5mg and 10mg for the proposed indication of healing of Gastroesophageal Reflux Disease (GERD), maintenance of healing of GERD and improvement of symptoms of GERD in children 1 to 11 years of age.

Acceptance of the NDA indicates that the FDA has found the company's submission to be sufficiently complete to review. The FDA assigned a Prescription Drug User Fee Act (PDUFA) date of March 27, 2013.

Source:

Posted in: Child Health News | Pharmaceutical News

Tags: Abdominal Pain, Acid Reflux, Antibody, Atazanavir, Children, Clostridium Difficile, Constipation, Diarrhea, Fever, Food, Gastroesophageal Reflux Disease, Headache, Heartburn, Methotrexate, Muscle, Nausea, Neuroscience, New Drug Application, Oncology, Pain, Prescription Drug, Sore Throat, Spine, Vomiting, Warfarin

Comments (0)

Download PDF Copy

Suggested Reading

Can you spot the difference? Study explores the appeal of AI-generated vs. real food images

Can you spot the difference? Study explores the appeal of AI-generated vs. real food images

Ultra-processed foods raise chronic kidney disease risk, study shows

Ultra-processed foods raise chronic kidney disease risk, study shows

Renaissance of "food as medicine" in modern clinical trials

Renaissance of "food as medicine" in modern clinical trials

Maternal influences on food allergy prevention: A closer look at diet and environment

Maternal influences on food allergy prevention: A closer look at diet and environment

Food allergies' broad impact on quality of life demands greater awareness

Food allergies' broad impact on quality of life demands greater awareness

How can food influence the severity of menopausal hot flashes?

How can food influence the severity of menopausal hot flashes?

Omalizumab boosts tolerance to multiple food allergies, study finds

Omalizumab boosts tolerance to multiple food allergies, study finds

New research sheds light on how GLP-1 obesity drugs may change food cravings

New research sheds light on how GLP-1 obesity drugs may change food cravings

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Study exposes food insecurity among graduate students and postdocs